nitrendipine has been researched along with Uremia in 1 studies
Nitrendipine: A calcium channel blocker with marked vasodilator action. It is an effective antihypertensive agent and differs from other calcium channel blockers in that it does not reduce glomerular filtration rate and is mildly natriuretic, rather than sodium retentive.
nitrendipine : A dihydropyridine that is 1,4-dihydropyridine substituted by methyl groups at positions 2 and 6, a 3-nitrophenyl group at position 4, a ethoxycarbonyl group at position 3 and a methoxycarbonyl group at position 5. It is a calcium-channel blocker used in the treatment of hypertension.
Uremia: A clinical syndrome associated with the retention of renal waste products or uremic toxins in the blood. It is usually the result of RENAL INSUFFICIENCY. Most uremic toxins are end products of protein or nitrogen CATABOLISM, such as UREA or CREATININE. Severe uremia can lead to multiple organ dysfunctions with a constellation of symptoms.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Nitrendipine treatment did not influence left ventricular mass (which was positively correlated with delta BW; p less than 0." | 2.67 | Salt and water retention and calcium blockade in uremia. ( Fabiani, F; Froment, L; Guerin, AP; London, GM; Marchais, SJ; Metivier, F; Safar, ME, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| London, GM | 1 |
| Marchais, SJ | 1 |
| Guerin, AP | 1 |
| Metivier, F | 1 |
| Safar, ME | 1 |
| Fabiani, F | 1 |
| Froment, L | 1 |
1 trial available for nitrendipine and Uremia
| Article | Year |
|---|---|
Salt and water retention and calcium blockade in uremia.
Topics: Aorta; Blood Chemical Analysis; Blood Pressure; Body Weight; Echocardiography; Heart Rate; Humans; H | 1990 |